Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Armata Pharmaceuticals Inc (ARMP)

Armata Pharmaceuticals Inc (ARMP)
1.8500 x 1 2.0500 x 1
Post-market by (Cboe BZX)
1.9500 -0.0200 (-1.02%) 03/14/25 [NYSE Arca]
1.8500 x 1 2.0500 x 1
Post-market 1.9500 unch (unch) 20:00 ET
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.9500
Day High
1.9920
Open 1.9700
Previous Close 1.9700 1.9700
Volume 1,600 1,600
Avg Vol 11,115 11,115
Stochastic %K 32.47% 32.47%
Weighted Alpha -44.33 -44.33
5-Day Change -0.0730 (-3.61%) -0.0730 (-3.61%)
52-Week Range 1.8000 - 4.2500 1.8000 - 4.2500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,557
  • Shares Outstanding, K 36,183
  • Annual Sales, $ 4,530 K
  • Annual Income, $ -69,050 K
  • EBIT $ -41 M
  • EBITDA $ -41 M
  • 60-Month Beta 0.89
  • Price/Sales 12.90
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.35
  • Number of Estimates 1
  • High Estimate -0.35
  • Low Estimate -0.35
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +36.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8100 +7.73%
on 03/11/25
Period Open: 1.9500
2.3000 -15.22%
on 02/21/25
unch (unch)
since 02/14/25
3-Month
1.8000 +8.33%
on 12/30/24
Period Open: 2.1918
2.3700 -17.72%
on 01/24/25
-0.2418 (-11.03%)
since 12/13/24
52-Week
1.8000 +8.33%
on 12/30/24
Period Open: 3.3800
4.2500 -54.12%
on 03/25/24
-1.4300 (-42.31%)
since 03/14/24

Most Recent Stories

More News
Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical stage biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
INVA : 17.39 (unch)
Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.02%)
Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata," "us," "our," or the "Company"), a biotechnology company focused on...

ARMP : 1.9500 (-1.02%)

Business Summary

Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including...

See More

Key Turning Points

3rd Resistance Point 2.0200
2nd Resistance Point 2.0060
1st Resistance Point 1.9780
Last Price 1.9500
1st Support Level 1.9360
2nd Support Level 1.9220
3rd Support Level 1.8940

See More

52-Week High 4.2500
Fibonacci 61.8% 3.3141
Fibonacci 50% 3.0250
Fibonacci 38.2% 2.7359
Last Price 1.9500
52-Week Low 1.8000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals